Afya Limited (Nasdaq: AFYA; B3: A2FY34), a prominent medical education group and medical practice solutions provider in Brazil, has announced the approval of a new share repurchase program. The Board of Directors has authorized the repurchase of up to 4,000,000 of its outstanding Class A common shares. The repurchase program will be conducted in open market or privately negotiated transactions starting from August 15, 2025, until the earlier of the completion of the repurchase or December 31, 2026. The repurchase is intended for use in Afya's stock option program, future business combinations, and other corporate purposes. The company plans to fund the repurchases using existing funds and future dividends.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.